Austin Retina Associates
Edward Lara is an experienced information technology professional currently serving as the Information Technology Manager at Austin Retina Associates since August 2022. Previously, Edward held multiple roles, including Senior IT Administrator, Network Administrator, and Network Technician at We Are Blood from November 2013 to August 2022. Edward's career began in the United States Marine Corps, where service included positions as Data Network Specialist, Communications Chief, and Data Chief Supervisor from October 2008 to October 2013. Edward is pursuing a Bachelor of Business Administration with a focus on Management Information Systems and Finance at the University of Houston, C.T. Bauer College of Business, expected to graduate in December 2025.
This person is not in any teams
Austin Retina Associates
Austin Retina Associates has been serving the citizens of Austin and surrounding communities since 1978. It is the largest retinal specialty group in Central Texas. Each of the highly respected retina physicians at Austin Retina Associates is a board-certified, licensed ophthalmologist and fellowship-trained retinal surgeon who is an expert in managing diseases involving the retina, vitreous and macula. The Austin Retina specialists concentrate on diabetic eye disease, retinal detachment, macular edema, epiretinal membrane, floaters, retinal surgery and more. Between them is over 100 years of combined medical knowledge and professional experience in providing patients with the very best vitreoretinal care available. ARA continues to remain at the forefront of retinal specialty practices by utilizing cutting-edge diagnostic equipment while offering state-of-the-art surgical procedures and pharmaceutical treatment regimens. ARA collaborates with referring ophthalmologists, optometrists, primary care physicians and specialists to comprehensively treat vitreoretinal disease. Additionally, Austin Retina Associates is nationally recognized for its participation in ground-breaking, pivotal clinical trials for 25 years, which has allowed us to offer our patients the opportunity to receive novel procedures and therapies through enrollment in research studies.